DENTSPLY SIRONA Inc. (LON:0I8F)
Market Cap | 2.16B |
Revenue (ttm) | 2.68B |
Net Income (ttm) | -692.68M |
Shares Out | n/a |
EPS (ttm) | -3.48 |
PE Ratio | n/a |
Forward PE | 7.67 |
Dividend | 0.49 (3.33%) |
Ex-Dividend Date | Jun 27, 2025 |
Volume | 149 |
Average Volume | 886 |
Open | 14.50 |
Previous Close | 14.23 |
Day's Range | 14.50 - 14.81 |
52-Week Range | 12.38 - 27.30 |
Beta | 0.97 |
RSI | 53.53 |
Earnings Date | Nov 6, 2025 |
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as w... [Read more]
Financial Performance
In 2024, DENTSPLY SIRONA's revenue was $3.79 billion, a decrease of -4.34% compared to the previous year's $3.97 billion. Losses were -$910.00 million, 589.4% more than in 2023.
Financial numbers in USD Financial StatementsNews

Dentsply Sirona (XRAY) Q2 2025 Earnings Transcript

Dentsply Sirona Grows Margins Amid Slump

Dentsply Sirona to Participate in Upcoming Investor Conferences
CHARLOTTE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Dentsply Sirona: Turnaround Potential And Digital Workflows
XRAY's EDS and Wellspect are the key to stabilizing their results going forward. OIS and CTS continue to decline, but SureSmile grows in Europe. Their new CEO will also prioritize execution, rather th...
DENTSPLY SIRONA outlines $80M annualized tariff headwind, maintains full-year outlook as new CEO signals accelerated transformation
Get detailed insights from DENTSPLY SIRONA's Q2 2025 earnings call. Discover strategies for accelerated transformation, tariff impacts & full-year outlook.
DENTSPLY SIRONA Inc. 2025 Q2 - Results - Earnings Call Presentation
DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript

Dentsply Sirona Maintains Outlook Despite Sales Decline
Dentsply Sirona Inc. (NASDAQ: XRAY) shares are trading lower on Thursday . The company reported second-quarter adjusted earnings per share of 52 cents, beating the analyst consensus estimate of 50 ce...
Dentsply Sirona declares $0.16 dividend

Dentsply Sirona Reports Second Quarter 2025 Results
CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2025.
Dentsply Sirona names Daniel Scavilla as new CEO, reaffirms 2025 outlook

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer
Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook
Braces, Bottlenecks And The Billion-Dollar Fix
The Hard Lessons Behind the Shift to Modern Orthodontic Care SmileDirectClub – once a high-flying DTC (direct-to-consumer) orthodontics startup – serves as a cautionary tale for healthcare investors. ...

Dental 3D Printing Market Forecast Study 2025, with Leading Dental Companies and Innovators BEGO, Dentsply Sirona, WhipMix, Straumann, Ivoclar, Formlabs, SprintRay, Asiga, and Shining3D
Explore the latest dental 3D printing market trends. Discover insights into dental segment growth, technological adoption, and 2024 revenue data of $5.2B. The market is poised to nearly double by 2033...

Dentsply Sirona to Host Second Quarter Conference Call on August 7th
CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and l...

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company")...

INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. and Encourages Long-Term Dentsply Investors to Contact the Firm - XRAY
PHILADELPHIA, PA / ACCESS Newswire / June 9, 2025 / Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Dentsply Sirona Inc. (NASDAQ:XRAY) ("Dentspl...

Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") ...
Dentsply Sirona prices offering of $550M of junior subordinated notes
Dentsply Sirona prices $550M notes at 8.375% due 2055 to repay debt and fund corporate purposes.